Opendata, web and dolomites

FRAME SIGNED

FRAME - tumor genome-based personalized anti-cancer vaccines off-the-shelf

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 FRAME project word cloud

Explore the words cloud of the FRAME project. It provides you a very rough idea of what is the project "FRAME" about.

strategy    frames    healthy    activate    ratio    checkpoint    expressed    breaking    discovered    read    types    economics    solution    benefit    therapeutic    cancer    patients    care    ground    consists    inhibitors    lung    50    breast    founder    imprcost    vaccine    clinical    neoantigens    ceo    therapeutics    months    routinely    individualized    entire    group    requiring    entirely    anti    health    shown    point    tumor    critical    time    alter    ambition    entrepreneurs    vaccination    patient    track    usually    first    off    melanoma    cancers    uterine    days    source    strategies    develops    colon    licensed    costly    vaccines    company    successful    effect    sequences    manufacturing    team    activation    frame    foreign    proqr    alone    frameshift    immune    reducing    shelf    kidney    dna    weeks    start    body    mutations    biotech    balanced    status    record    crucell    shift    dutch    quo    treatment    shared    combine    personalized   

Project "FRAME" data sheet

The following table provides information about the project.

Coordinator
FRAME PHARMACEUTICALS BV 

Organization address
address: Science Park 106
city: AMSTERDAM
postcode: 1098 XG
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2020-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FRAME PHARMACEUTICALS BV NL (AMSTERDAM) coordinator 50˙000.00

Map

 Project objective

Frame Cancer Therapeutics is a Dutch start-up that develops effective vaccines against cancer, based on frameshift mutations. Driven by the ambition to provide a therapeutic effect for up to 50% of all cancers, Frame aims to alter the status quo of cancer treatment. Our balanced team consists of top researchers and successful biotech entrepreneurs with a track record including the CEO of Crucell , and founder of ProQR.

The clinical use of so-called checkpoint inhibitors, which activate the immune system, has shown great effects, particularly for treatment of advanced melanoma. Yet, a large group of cancer patients does not benefit from this treatment alone, and the next step is to combine this general activation of the immune system with tumor-specific vaccination. This has just become possible now that entire tumor DNA sequences get to be routinely read within two weeks, as part of clinical care.

The solution that Frame Cancer Therapeutics has developed is a ground-breaking strategy for anti-cancer vaccination using off-the-shelf yet personalized cancer vaccines derived from frameshift mutations. Frame Therapeutics has discovered FRAMES, a source of shared neoantigens induced by frame-shift mutations with unique therapeutic potential. These sequences are usually not expressed in the healthy body, and thus seen as foreign by the immune system. A licensed sets of FRAMES are each specific vaccines for different tumor types (such as breast, lung, kidney, colon, uterine cancer).

Most cancer vaccination strategies are based on point mutations unique for each tumor, requiring costly individualized vaccine manufacturing. Frame Therapeutics is the first company entirely focusing on the development of cancer vaccines based on FRAMES, offering off-the-shelf personalized cancer vaccines. This approach allows for economics of scale, reducing time to treatment from months to days, which is critical to patient health, and which will imprcost/benefit ratio’s.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FRAME" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "FRAME" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More  

LIVELMIA (2019)

Innovative assay for microRNAs analysis

Read More  

IRMELI (2019)

AI-BASED BROKERING TECHNOLOGY PLATFORM TO FIND THE PERFECT MATCH BETWEEN THE CUSTOMER AND BANK

Read More